|
Treatment and crude mortality among transferred v non-transferred patients and rural v urban patients |
||||||
| Non-Transferred N = 132,765 |
Transferred N = 51,530 |
Urban N = 148,471 |
Rural N = 35,824 |
|||
|
|
||||||
| Continuous Variables |
||||||
|
|
||||||
| Mean |
Mean |
p-value |
Mean |
Mean |
p-value |
|
|
|
||||||
| Length of Stay |
8.2 |
5.9 |
< 0.001 |
7.9 |
5.9 |
< 0.001 |
| Categorical Variables |
||||||
|
|
||||||
| % |
% |
% |
% |
|||
|
|
||||||
| ASA if Eligible |
84 |
89 |
< 0.001 |
87 |
82 |
< 0.001 |
| Beta Blocker if Eligible |
50 |
57 |
< 0.001 |
54 |
44 |
< 0.001 |
| ACE-I if Eligible |
33 |
21 |
< 0.001 |
31 |
28 |
< 0.001 |
| Thrombolytics if Eligible |
53 |
71 |
< 0.001 |
58 |
62 |
< 0.001 |
| Tobacco Cessation Counseling |
6 |
6 |
0.02 |
6 |
5 |
< 0.001 |
| Died Within 30 Days |
19 |
11 |
< 0.001 |
16 |
18 |
< 0.001 |
Westfall et al. BMC Cardiovascular Disorders 2008 8:22 doi:10.1186/1471-2261-8-22 |
||||||